Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ocuphire Pharma, Inc. | SVP of Corp. Dev. | Common Stock | 163K | $531K | $3.27 | Jan 18, 2024 | Direct |
Ocuphire Pharma, Inc. | SVP of Corp. Dev. | Employee Stock Option (right to buy) | 30K | Jan 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OCUP | Ocuphire Pharma, Inc. | Jan 18, 2024 | 2 | $0 | 4 | Jan 22, 2024 | SVP of Corp. Dev. |
OCUP | Ocuphire Pharma, Inc. | Jan 10, 2024 | 1 | -$13.2K | 4 | Jan 12, 2024 | SVP of Corp. Dev. |
OCUP | Ocuphire Pharma, Inc. | Jan 10, 2023 | 2 | $0 | 4 | Jan 12, 2023 | SVP of Corp. Dev. & Ops & Sec. |
OCUP | Ocuphire Pharma, Inc. | Jan 28, 2022 | 1 | $0 | 4 | Feb 1, 2022 | VP of Corp. Dev. & Ops & Sec. |